Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment
Chimeric antigen receptor (CAR) T cell therapy has emerged as a groundbreaking treatment for hematological cancers, yet it faces significant hurdles, particularly regarding its efficacy in solid tumors and concerning associated adverse effects. This review provides a comprehensive analysis of the ad...
Saved in:
Main Authors: | Xuejia Kang (Author), Nur Mita (Author), Lang Zhou (Author), Siqi Wu (Author), Zongliang Yue (Author), R. Jayachandra Babu (Author), Pengyu Chen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chimeric antigen receptor T cell therapy for multiple myeloma
by: Kana Hasegawa, et al.
Published: (2019) -
Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development
by: Johannes Kast, et al.
Published: (2022) -
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
by: Zixun Yin, et al.
Published: (2021) -
The FDA's Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies
by: Peter Marks
Published: (2019) -
Biomarkers in individualized management of chimeric antigen receptor T cell therapy
by: Mengyi Du, et al.
Published: (2020)